<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="159">
  <stage>Registered</stage>
  <submitdate>9/08/2005</submitdate>
  <approvaldate>31/08/2005</approvaldate>
  <actrnumber>ACTRN12605000249651</actrnumber>
  <trial_identification>
    <studytitle>Effects of acute oxygen therapy on cognitive and driving performance in hypoxaemic COPD.</studytitle>
    <scientifictitle>Effects of acute oxygen therapy on cognitive and driving performance in hypoxaemic COPD.</scientifictitle>
    <utrn />
    <trialacronym>DriveOx</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Hypoxaemic COPD</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Chronic obstructive pulmonary disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Cognitive function and driving performance on a computerised driving simulator are measured before and after intranasal oxygen at a flow rate known to relieve hypoxaemia. Duration of each intervention is approximately 40 minutes</interventions>
    <comparator>The control arm involves the same tests on the same patients whilst breathing medical air at the same gas flow rate.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Driving performance on a computerised driving simulator</outcome>
      <timepoint>Measured at baseline and after acute exposure to the gas being studied.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cognitive function assessed using a psychomotor vigilance task (PVT).</outcome>
      <timepoint>At baseline and after acute exposure to the gas being studied.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Clinical diagnosis of COPD, demonstrated hypoxaemia at rest on room air (PaO2&lt;60mmHg) and demonstrated adequate reversal of hypoxaemia (to &gt;60mmHg) with supplemental oxygen, current driving licence.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes</concealment>
    <sequence>Randomization performed using published table of random numbers (odd/even) in Statistics at square one. 9th ed., p138 TDV Swinscow BMJ Publishing group, 1996. ISBN 0-7279-0916-9</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/07/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Institute for Breathing and Sleep</primarysponsorname>
    <primarysponsoraddress>Studley Road
Heidelberg VIC 3081</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Victorian Tuberculosis and Lung Association</fundingname>
      <fundingaddress>341 Queen Street
Melbourne CBD VIC 3000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Austin Hospital</sponsorname>
      <sponsoraddress>Studley Road
Heidelberg VIC 3081</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication>Respirology (2008), 13: 1039-44 (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18764913)</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Hospital</ethicname>
      <ethicaddress>Heidelberg VIC</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jeff Pretto</name>
      <address>Department of Respiratory &amp; Sleep Medicine
John Hunter Hospital
Newcastle NSW</address>
      <phone>+61 2 49223150</phone>
      <fax>+61 2 49223160</fax>
      <email>jeff.pretto@hnehealth.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jeff Pretto</name>
      <address>Department of Respiratory &amp; Sleep Medicine
John Hunter Hospital
Newcastle NSW</address>
      <phone>+61 2 49223150</phone>
      <fax>+61 2 49223160</fax>
      <email>jeff.pretto@hnehealth.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>